Suppr超能文献

在生物制药行业筹集风险资本。

Raising venture capital in the biopharma industry.

作者信息

Leytes Lev J

机构信息

Generation Capital, LLC, c/o VAI, 1190 Bordeaux Drive, Sunnyvale, CA 94089, USA.

出版信息

Drug Discov Today. 2002 Nov 15;7(22):1125-7. doi: 10.1016/s1359-6446(02)02500-x.

Abstract

Raising venture capital (VC) is both an art and a science. Future entrepreneurs should carefully consider the various issues of VC financing that have a strong impact on the success of their business. In addition to attracting the best venture capital firms, these issues include such subtle but important points as the timing of financing (especially of the first round), external support sources, desirable qualities of a VC firm, amount to be raised, establishing a productive interface between the founders and the venture capitalists, and most importantly the effects of well-executed VC funding on hiring senior executives and scientific leaders.

摘要

筹集风险资本既是一门艺术,也是一门科学。未来的企业家应仔细考虑风险资本融资的各种问题,这些问题对其企业的成功有着重大影响。除了吸引最佳风险投资公司外,这些问题还包括融资时机(尤其是首轮融资时机)、外部支持来源、风险投资公司的理想特质、融资数额、在创始人与风险资本家之间建立富有成效的沟通界面,以及最重要的是,执行良好的风险资本融资对招聘高级管理人员和科学领军人物的影响等细微但重要的方面。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验